Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.

We analyzed the urine samples of patients with type 2 diabetes at various stages of diabetic nephropathy by lectin microarray to identify a biomarker to predict the progression of diabetic nephropathy. Japanese patients with type 2 diabetes at various stages of nephropathy were enrolled and we perfo...

Full description

Bibliographic Details
Main Authors: Kentaro Inoue, Jun Wada, Jun Eguchi, Atsuko Nakatsuka, Sanae Teshigawara, Kazutoshi Murakami, Daisuke Ogawa, Takahiro Terami, Akihiro Katayama, Atsuhito Tone, Izumi Iseda, Kazuyuki Hida, Masao Yamada, Tomohisa Ogawa, Hirofumi Makino
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3797112?pdf=render
id doaj-e1e5458e6c9e46c1b7862d7317f16ddb
record_format Article
spelling doaj-e1e5458e6c9e46c1b7862d7317f16ddb2020-11-24T21:54:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7711810.1371/journal.pone.0077118Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.Kentaro InoueJun WadaJun EguchiAtsuko NakatsukaSanae TeshigawaraKazutoshi MurakamiDaisuke OgawaTakahiro TeramiAkihiro KatayamaAtsuhito ToneIzumi IsedaKazuyuki HidaMasao YamadaTomohisa OgawaHirofumi MakinoWe analyzed the urine samples of patients with type 2 diabetes at various stages of diabetic nephropathy by lectin microarray to identify a biomarker to predict the progression of diabetic nephropathy. Japanese patients with type 2 diabetes at various stages of nephropathy were enrolled and we performed lectin microarray analyses (n = 17) and measured urinary excretion of fetuin-A (n = 85). The increased signals of urine samples were observed in Siaα2-6Gal/GalNAc-binding lectins (SNA, SSA, TJA-I) during the progression of diabetic nephropathy. We next isolated sialylated glycoproteins by using SSA-lectin affinity chromatography and identified fetuin-A by liquid chromatography-tandem mass spectrometer. Urinary excretion of fetuin-A significantly increased during the progression of albuminuria (A1, 0.40 ± 0.43; A2, 0.60 ± 0.53; A3 1.57 ± 1.13 ng/gCr; p = 7.29 × 10(-8)) and of GFR stages (G1, 0.39 ± 0.39; G2, 0.49 ± 0.45; G3, 1.25 ± 1.18; G4, 1.34 ± 0.80 ng/gCr; p = 3.89 × 10(-4)). Multivariate logistic regression analysis was employed to assess fetuin-A as a risk for diabetic nephropathy with microalbuminuria or GFR<60 mL/min. Fetuin-A is demonstrated as a risk factor for both microalbuminuria and reduction of GFR in diabetic nephropathy with the odds ratio of 4.721 (1.881-11.844) and 3.739 (1.785-7.841), respectively. Collectively, the glycan profiling analysis is useful method to identify the urine biomarkers and fetuin-A is a candidate to predict the progression of diabetic nephropathy.http://europepmc.org/articles/PMC3797112?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kentaro Inoue
Jun Wada
Jun Eguchi
Atsuko Nakatsuka
Sanae Teshigawara
Kazutoshi Murakami
Daisuke Ogawa
Takahiro Terami
Akihiro Katayama
Atsuhito Tone
Izumi Iseda
Kazuyuki Hida
Masao Yamada
Tomohisa Ogawa
Hirofumi Makino
spellingShingle Kentaro Inoue
Jun Wada
Jun Eguchi
Atsuko Nakatsuka
Sanae Teshigawara
Kazutoshi Murakami
Daisuke Ogawa
Takahiro Terami
Akihiro Katayama
Atsuhito Tone
Izumi Iseda
Kazuyuki Hida
Masao Yamada
Tomohisa Ogawa
Hirofumi Makino
Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
PLoS ONE
author_facet Kentaro Inoue
Jun Wada
Jun Eguchi
Atsuko Nakatsuka
Sanae Teshigawara
Kazutoshi Murakami
Daisuke Ogawa
Takahiro Terami
Akihiro Katayama
Atsuhito Tone
Izumi Iseda
Kazuyuki Hida
Masao Yamada
Tomohisa Ogawa
Hirofumi Makino
author_sort Kentaro Inoue
title Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
title_short Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
title_full Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
title_fullStr Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
title_full_unstemmed Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
title_sort urinary fetuin-a is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description We analyzed the urine samples of patients with type 2 diabetes at various stages of diabetic nephropathy by lectin microarray to identify a biomarker to predict the progression of diabetic nephropathy. Japanese patients with type 2 diabetes at various stages of nephropathy were enrolled and we performed lectin microarray analyses (n = 17) and measured urinary excretion of fetuin-A (n = 85). The increased signals of urine samples were observed in Siaα2-6Gal/GalNAc-binding lectins (SNA, SSA, TJA-I) during the progression of diabetic nephropathy. We next isolated sialylated glycoproteins by using SSA-lectin affinity chromatography and identified fetuin-A by liquid chromatography-tandem mass spectrometer. Urinary excretion of fetuin-A significantly increased during the progression of albuminuria (A1, 0.40 ± 0.43; A2, 0.60 ± 0.53; A3 1.57 ± 1.13 ng/gCr; p = 7.29 × 10(-8)) and of GFR stages (G1, 0.39 ± 0.39; G2, 0.49 ± 0.45; G3, 1.25 ± 1.18; G4, 1.34 ± 0.80 ng/gCr; p = 3.89 × 10(-4)). Multivariate logistic regression analysis was employed to assess fetuin-A as a risk for diabetic nephropathy with microalbuminuria or GFR<60 mL/min. Fetuin-A is demonstrated as a risk factor for both microalbuminuria and reduction of GFR in diabetic nephropathy with the odds ratio of 4.721 (1.881-11.844) and 3.739 (1.785-7.841), respectively. Collectively, the glycan profiling analysis is useful method to identify the urine biomarkers and fetuin-A is a candidate to predict the progression of diabetic nephropathy.
url http://europepmc.org/articles/PMC3797112?pdf=render
work_keys_str_mv AT kentaroinoue urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT junwada urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT juneguchi urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT atsukonakatsuka urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT sanaeteshigawara urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT kazutoshimurakami urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT daisukeogawa urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT takahiroterami urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT akihirokatayama urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT atsuhitotone urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT izumiiseda urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT kazuyukihida urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT masaoyamada urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT tomohisaogawa urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
AT hirofumimakino urinaryfetuinaisanovelmarkerfordiabeticnephropathyintype2diabetesidentifiedbylectinmicroarray
_version_ 1725866362578927616